Naltrexone Should Be Recommended
For this 48-year-old man with alcohol use disorder who wants to reduce consumption but cannot do so independently, naltrexone is the most appropriate first-line pharmacotherapy to recommend now, combined with counseling. 1
Rationale for Naltrexone
Naltrexone is specifically indicated for patients who:
- Are actively drinking and want to reduce consumption (not just maintain abstinence)
- Have failed behavioral modification attempts alone
- Do not have evidence of severe liver disease
- Are motivated for treatment
The guidelines explicitly state that naltrexone or acamprosate may be considered in combination with counseling to decrease the likelihood of relapse in patients with alcohol abuse/dependence (Class I, level A recommendation). 1
Naltrexone works as a pure opioid antagonist that controls alcohol craving and has been shown in Cochrane systematic reviews to lower the risk of relapse when used short-term. 1 It reduces heavy drinking days and helps patients who are still consuming alcohol to cut down. 2
Why Not the Other Options
Acamprosate is specifically designed for maintaining abstinence in patients who have already achieved detoxification and stopped drinking. 1, 3 The evidence clearly states it "has not been shown to have a significant impact on alcoholics who have not been detoxified or become abstinent." 1 Since this patient is currently drinking 5-6 drinks per event, acamprosate is not appropriate at this stage.
Disulfiram has limited evidence supporting its effectiveness and poor tolerability. 1 Multiple guidelines note that "there was little evidence that disulfiram enhances abstinence, and based on its poor tolerability, its use has been largely supplanted by newer agents." 1 The FDA label confirms it requires full patient knowledge and is merely an "aid" requiring proper motivation. 4 It works through aversive therapy rather than reducing cravings, making it less suitable for someone not yet committed to complete abstinence.
12-step program referral alone without pharmacotherapy misses the opportunity to provide evidence-based medical treatment. While psychosocial interventions are important adjuncts, the guidelines emphasize that pharmacotherapy combined with counseling is more effective than either alone. 1, 3
Important Clinical Considerations
Before prescribing naltrexone:
- Verify the patient does not have severe liver disease (naltrexone can cause hepatocellular injury and is contraindicated in acute hepatitis or liver failure) 1, 3
- Check baseline liver function tests and monitor every 3-6 months 5
- Ensure the patient is not taking opioids for pain management (naltrexone will block their effects) 6
- Confirm the patient is not currently physically dependent on opioids (naltrexone will precipitate withdrawal) 6
Dosing: Start with 25 mg for 1-3 days, then increase to 50 mg once daily for 3-6 months (can extend to 12 months). 3
Essential combination with counseling: Naltrexone must be prescribed alongside psychosocial support—this is not optional. The medication works synergistically with behavioral interventions to achieve optimal outcomes. 1 Brief interventions, motivational interviewing, or cognitive behavioral therapy should be initiated concurrently.
Common Pitfall to Avoid
The most critical error would be prescribing naltrexone without first assessing liver function. Given this patient's unremarkable exam, there's no obvious evidence of advanced liver disease, but biochemical testing is mandatory before initiation. The second major pitfall is prescribing medication without arranging concurrent counseling or psychosocial support—pharmacotherapy alone is insufficient.